NervGen Pharma Corp (NGEN) — Working Capital to Net Assets Ratio
NervGen Pharma Corp (NGEN) has a Working Capital to Net Assets ratio of 114.4% as of September 2025. Working capital of CA$-3.36 Million (current assets of CA$12.65 Million minus current liabilities of CA$16.02 Million) is measured against net assets of CA$-2.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See NGEN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NervGen Pharma Corp Working Capital to Net Assets (2017–2024)
This chart shows how NervGen Pharma Corp's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 114.4%, reflecting working capital of CA$-3.36 Million against net assets of CA$-2.94 Million CAD. See operational self-sufficiency of NervGen Pharma Corp to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for NervGen Pharma Corp (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for NervGen Pharma Corp from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see NervGen Pharma Corp market capitalisation.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 82.0% | CA$2.11 Million | CA$2.58 Million | CA$19.01 Million | CA$16.90 Million | ▼ -48.7 pp |
| 2023 | 130.6% | CA$-2.62 Million | CA$-2.01 Million | CA$12.52 Million | CA$15.14 Million | ▲ +34.5 pp |
| 2022 | 96.1% | CA$12.93 Million | CA$13.46 Million | CA$23.15 Million | CA$10.22 Million | ▼ -1.1 pp |
| 2021 | 97.2% | CA$16.34 Million | CA$16.82 Million | CA$17.42 Million | CA$1.08 Million | ▲ +5.2 pp |
| 2020 | 92.0% | CA$5.45 Million | CA$5.92 Million | CA$6.20 Million | CA$755.07K | ▲ +0.7 pp |
| 2019 | 91.3% | CA$5.33 Million | CA$5.84 Million | CA$6.26 Million | CA$923.95K | ▲ +7.7 pp |
| 2018 | 83.6% | CA$2.10 Million | CA$2.51 Million | CA$2.55 Million | CA$448.88K | ▼ -721.2 pp |
| 2017 | 804.7% | CA$-95.06K | CA$-11.81K | CA$0.00 | CA$95.06K | — |